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Abstract 
 
Relationships between health and economic prosperity or economic growth are difficult 
to assess. The direction of the causality is often questioned and the subject of a vigorous 
debate. For some authors, diseases or poor health had contributed to poor growth 
performances especially in low-income countries. For other authors, the effect of health on 
growth is relatively small, even if one considers that human capital accumulation needs also 
health investments. It is argued in this paper that commonly used health indicators in 
macroeconomic studies (e. g. life expectancy, infant mortality or prevalence rates for specific 
diseases such as malaria or HIV/AIDS) imperfectly represent the global health status of 
population. Health is rather a complex notion and includes several dimensions which 
concern fatal (deaths) and non-fatal issues (prevalence and severity of cases) of illness. The 
reported effects of health on economic growth vary accordingly with health indicators and 
countries included in existing analyses. The purpose of the paper is to assess the effect of 
health on growth, by using a global health indicator, the so-called disability-adjusted life year 
(DALY) that was proposed by the World Bank and the WHO in 1993. Growth convergence 
equations are run on 159 countries over the 1999-2004’s period, where the potential 
endogeneity of the health indicator is dealt for. The negative effect of poor health on 
economic growth is not rejected thus reinforcing the importance of achieving MDGs. 
 
 
JEL Classification: E22, E24, I19, I18, O47 
 
Key Words: Disease Global Burden, DALYs, economic growth, macroeconomic health impact, 
cross-country analysis  
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Introduction 
Human capital investments are known for a long time as basic candidates explaining 
growth performances (e. g. Schultz, 1961). Sen’s works on human capabilities and the 
emergence of AIDS have renewed the interest given to the link between health, welfare, and 
prosperity. At a microeconomic level, several studies found that poor health have negative 
effects on economic prosperity and living conditions.1 At a macroeconomic level, the 
Commission on Macroeconomics and Health (2001) concluded that diseases raise barriers to 
economic growth and that countries have to invest in health. Several authors have considered 
that communicable diseases, among others, had contributed to slow down economic 
development of low income countries. The latter proposition is still hotly debated as some 
methodological issues are not satisfactorily addressed (see the comprehensive and critical 
review of Packard, 2009). Acemoglu and Johnson (2006), using international data from the 
epidemiological transition period, find that an increase in life expectancy generated by a 
decrease in mortality rates had a small positive effect which grows over the post 
epidemiological transition. The latter was not enough important to compensate for increases 
in population. Consequently, life expectancy increases do not lead to a significant increase in 
per capita economic growth. This study makes reminiscent previous results of Barlow (1968) 
with regard to malaria eradication and of Over (1992) with regard to economic effects of 
AIDS as well. In the same vein, Bell, Bruhns and Gersbach (2006), using an overlapping 
generations model simulate relaxed effects of AIDS on economic growth in Kenya by 2050.  
There are at least three reasons that could explain difficulties to assess health impacts at the 
macroeconomic level and therefore fuel the debate. First, links between health and 
development or growth are complex and health effect could also be channelled into education 
levels, the environment, and cultural behaviours as well. When, due to missing adequate 
indicators, these behaviours are not included in the model, the estimated health effect will be 
biased or hidden by unobserved heterogeneity (Thomas, 2009; Strauss and Thomas, 2007). 
Second, health is subject to measurement errors either due to poor measurement facilities such 
as lack of good equipment and materials for setting appropriate diagnosis, low human 
resource training, deficient registration, measurement variability over the day (e.g. blood 
pressure) or the year (e. g. malaria indicators). Third, health status is a rather complex notion 
that includes several dimensions. Researchers face a wide array of health indicators 
                                                 
1
 The literature on links between health and economic well-being or prosperity at microeconomic level is 
abundant. See Strauss and Thomas (2007) for an exhaustive literature review. 
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addressing one specific dimension of health. Consequently, using one or the other is not 
equivalent. 
Partly due to these difficulties of measuring multiple dimensions of health and therefore 
global health, macroeconomic effects of health have been more still studied using health 
indicators such as life expectancy at birth, infant mortality rates, or nutritional status 
measures. Existing results can be questioned by addressing specifically the choice of health 
status indicators, which is the subject of this study. 
The rest of the paper is organized as follows. Section 2 is devoted to health measurement 
issue. Different measures of health indicators used in the growth literature are discussed 
before exploring the more global one on which is focused this study. Section 3 reviews the 
theoretical and empirical literature on the link between health outcomes and economic 
performances. The empirical setting and the results are presented in section 4 and 5. Section 6 
concludes.  
1. Looking for a global health indicator 
Health measurement is a hard task since, contrary to economic indicators, health is multi-
dimensional,2 and measured with errors. Moreover, researchers, either in a perspective of 
public health initiatives, health research, or economic health research, have developed a wide 
array of health indicators, among which few however are satisfactorily measured (Murray and 
Frenk, 2008; Murray, 2007).3 If it is crucial to understand what each indicator measures 
(Strauss and Thomas, 2008), it is also important to insure that health indicators fit the 
purposes of studies 
The most commonly used indicators of health conditions at the macroeconomic level are 
life expectancy at birth and infant mortality rates (Strauss and Thomas, 2008). Those 
indicators are considered reflecting the general health conditions and supposed to be 
positively associated with economic growth. It is true that life expectancy is higher and infant 
mortality lower in richer countries than in poorer countries. Indeed, the correlation between 
life expectancy at birth and GDP per capita is not systematic as life expectancy is lower (or 
                                                 
2
 Whatever the approach chosen (medical, self-assessment or functional) for measuring health, poor health is 
considering as a deviation between the observed health and a norm. This deviation may occur into either, 
physical, mental, or social well-being dimension.  
3
 For a discussion on the issue and challenge of health measurement, see Mwabu, 2007; Strauss and Thomas, 
2008; Murray and Frenk, 2008; Audibert, 2009).  
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higher) than expected given GDP per capita in countries like Southern Africa, Gabon or 
Indonesia (for examples, see Strauss and Thomas, 2008). Per capita incomes have diverged 
over time while life expectancy and infant mortality have converged (Deaton, 2006; Jack and 
Lewis, 2009). Life expectancy and infant mortality are inadequate indicators of the 
population’s health in high income countries and for several upper middle income countries 
where life expectancy is high and infant mortality is very low or low. For low and lower 
middle income countries, those indicators are more adequate due to their poor levels. For that 
reason, studying the relationships between health and economic development or growth in 
cross-country studies using infant mortality or life expectancy at birth is not really 
appropriate.  
As underlined by Jack and Lewis (2009), the effect of a population’s health status on 
national income varies accordingly with the health indicator used. Most health indicators used 
in the literature capture one dimension of the population health. They either relate to fatal (life 
expectancy,4 mortality indicators) or to non-fatal (morbidity indicators) issue of illness 
(Audibert, 2009). For example, the emergence of HIV/AIDS and its high prevalence (more 
than 15%) in some southern African countries (Botswana, Lesotho, Namibia, South Africa, 
Swaziland, Zambia, and Zimbabwe, UNAIDS5), have motivated several studies focusing on 
their economic effects. But, little evidence of a correlation between HIV/AIDS and GDP per 
capita was found (Strauss and Thomas, 2008). With the renewed interest for malaria, some 
authors (Sachs and Malaney, 2002; McCarthy, Wolf and Wu, 2000) have investigated its 
effect on African countries growth. But, those indicators neither take into account other 
dimensions of health, such as invalidity, handicap or social consequences, nor 
multidimensional characteristics of health.  
The main thesis of this paper is that macroeconomic effects of the global health status are 
accurately caught by the Disability-Adjusted Life Year (DALY) per capita calculated by the 
World Health Organization (WHO). This indicator is proposed by the World Bank and WHO 
since 1993 (the World Bank, 1993). Its represents “a one lost year of healthy life and extends 
the concept of potential years of life lost due to premature death to include equivalent years of 
                                                 
4
 In low income countries, life expectancy is mainly determined by infant mortality, and also in countries where 
AIDS prevalence is high, by AIDS mortality. 
5
 http://www.unaids.org/en/CountryResponses/Regions/SubSaharanAfrica.asp. 
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healthy life lost by virtue of being in states of poor health or disability” (WHO, 2008).6 “The 
sum of these DALYs across the population represents the burden of disease and can be 
thought of as a measurement of the gap between current health status and an ideal health 
situation where the entire population lives to an advanced age, free of disease and disability” 
(WHO, 2008). DALYs were calculated initially for about one hundred causes and diseases 
and over the whole world and were not updated since 2000. From 2000 to 2004 however, 
DALYs are also available on a regional basis. DALYs are commonly used in cost-
effectiveness analyses but, to the best of our knowledge, have never been used in 
macroeconomic analyses since DALYs at the country level are only available for 2002 and 
2004. 
Any indicator, including DALYs, is amenable to criticism with a particular emphasis on 
weighting (namely age and disease severity) and discounting (e.g. Anand and Hanson, 1998). 
A large revision has been however implemented, mainly by the Institute of Health Metrics, 
which is in charge DALYs calculations updates and improvements (Lopez et al, 2006). This 
does not prevent however this indicator from being a serious candidate for representing 
population global health status, deriving from illness consequences which are taken into 
consideration in a single indicator. 
Figures 1B, 2B, 3B and 4B, Appendix B, present the relationships between different 
DALY indicators and traditional health measures (Life expectancy, Infant Mortality Rate and 
Child Mortality Rate) as well as GDP per capita. It appears clearly that even though there is a 
tight association between DALYs and traditional health indicators, the correlation between 
them is far from perfect.  
2. Relationship between health and growth 
 
This paper builds on the idea of health being a capital: people are endowed an initial stock 
which can depreciate through time with age but which is the subject of investments 
(Grossman, 1972; see Mwabu, 2007 for a literature review on the concept of health capital). 
                                                 
6
 The DALYs for each health condition are the sum of the years of life lost (YLL) due to premature mortality 
and the years lost due to disability (YLD) for incident cases of the health condition. YLL are calculated from the 
number of deaths at each age multiplied by a global standard life expectancy for each age. YLD is the number of 
incident cases in a particular period × average duration of the disease × weight factor. The weight factor reflects 
the severity of the disease on a scale from 0 (perfect health) to 1 (death). For additional information, see WHO, 
http://www.who.int/healthinfo/global_burden disease/metrics_daly/en/. 
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From such a perspective, Van Zon and Muysken (2005) mention two positive effects of health 
on economic growth. First, the health status of population increases the efficiency of labour; 
second, human capital accumulation requires “health hours”. These effects add to those of 
Bloom and Canning (2000) who argue that improvements in longevity increase savings and in 
turn investments; moreover there exists a demographic dividend generated by a decline in 
child mortality. The effect of health on economic growth has also been the subject of 
theoretical investigations. One may refer to the augmented Solow model developed and tested 
by Mankiw et al. (1992). Other authors have included health in optimal Cass-Koopmans like 
growth models and thereby justified its inclusion in conditional convergence analyses as well: 
the productivity in the health sector has a positive impact on all steady state variables 
(Muysken et al. 2003). At last, health investments are taken into account in endogenous 
growth models à la Lucas (1988) with two characteristics: health is produced with decreasing 
returns whereas human capital is built with increasing returns. Health can either be a 
complement or a substitute to growth when the effect of health on longevity is internalised 
(van Zon & Muysken, 2001). Neo-schumpeterian growth models also allow identifying 
several channels through which population health impacts their long run growth performance. 
One of these channels puts forward the ability of health improvements to stabilise the gap in 
living standards relatively to technology leaders (Howitt, 2005). 
If at a micro-level, empirical studies found that poor health has an economic effect through 
several channels (e.g. Audibert 2010), this effect is less evident at a macro-level. The 
Preston’s curb (1975) establishes an upward shifting relationship between life expectancy and 
national income per capita between 1900 and 1960. This correlation however neither gives 
pieces information on the sense of the causality nor on the different channels through which 
health may impact economic growth. 
These channels may be identified. The first is that healthier people are more productive 
and supply labour more efficiently. Indeed, they can work harder and longer, and think more 
clearly. Health status may also improve economic outcomes through its effect on education. 
Improvements in health raise the motivation to attend high level schooling, since the returns 
to investments in schooling are valuable over a longer working life. Healthier children and 
students also have more attendance and higher cognitive functioning, and thus receive a better 
education for a given level of schooling. Furthermore lower mortality rates and higher life 
expectancy encourage savings for retirement, and thus raise investment levels and capital per 
CERDI, Etudes et Documents, E 2012.12 
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worker. Table A8 in Appendix A gives a synthesis of some of the main studies that explored 
the connection between health and economic prosperity. We discuss here some major results. 
Some scholars assess empirically how health indicators may influence economic returns in 
a specific region using individual or household data while others measure the same effect at 
more aggregated level, between countries or regions. All these studies could be divided 
according to the health indicators considered. Indeed, a number of studies utilize health inputs 
whereas others used health outcomes. Health inputs are the physical factors that influence an 
individual’s health and comprise nutrition variables, exposure to pathogens, and the 
availability of medical care (Weil, 2007). Health outcomes are related to the health status of 
an individual or a given population. These include health indicators broadly considered such 
as life expectancy, mortality indicators, the ability to work hard, and cognitive functioning as 
well as specific illness prevalence such as malaria, AIDS/HIV, Guinea worm, etc.   
Researchers generally conclude that population health remains an important predictor of 
economic outcomes. Life expectancy at birth positively impact economic performances 
(Barro & Lee, 1994; Cuddington & Hancock, 1994; Barro & Sala-I-Martin, 1995; Barro, 
1996; Sach & Warner, 1997; Bloom & Malaney, 1998; Bloom et al., 2000, 2005, 2009; 
Arora, 2001; Acemoglu & Johnson, 2007, 2009). Bloom et al. (2004) show that life 
expectancy has a positive, sizable, and statistically significant effect on aggregate output even 
when experience of the workforce is controlled for. Sala-i-Martin et al. 2004 departing from 
the numerous potential explanatory variables in cross-country growth regressions, implement 
a model selection criterion. The set of explanatory variables which emerges from the analysis 
includes human capital variables and more especially life expectancy at birth. Acemoglu and 
Johnson’s results (2007) are less conclusive with results indicating that increases in life 
expectancy have no significant effect on output per capita.7  
Mortality or survival variables are also used in the literature as overall health outcome 
indicators that impact economic growth (Hamoudi & Sachs, 1999; Bhargava et al. 2001; 
Weil, 2007; Lorentzen et al. 2005). Using cross-national and sub-national data, Lorentzen et 
al. (2005) argue that high adult mortality rates reduce economic growth by shortening time 
horizons since they favour riskier behaviours, higher fertility rates, and lower investments in 
physical capital. Other authors are interested in the impact of specific diseases on economic 
                                                 
7
 Even though, Bloom, Canning & Fink (2009) disagree with their results, Acemoglu and Johnson still 
maintained their position in their 2009 paper. 
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returns. In fact, many diseases like HIV/AIDS and malaria are found to have a negative effect 
on the economy (Cuddington & Hancock, 1994; Gallup & al, 1999; Bonnel, 2000; Gallup & 
Sachs, 2001; Sachs, 2003; Bell, Devarajan and Gerbasch 2003; McDonald & Roberts, 2006; 
Audibert et al., 1998, 1999, 2003, 2006, 2009). McDonald & Roberts (2006) have calculated 
that the elasticity of economic growth to HIV/AIDS prevalence in Africa is -0.59. Carstensen 
& Gundlach (2006) found that malaria prevalence causes quantitatively important negative 
effects on income even after controlling for institutional quality. Wiping out malaria from 
sub-Saharan Africa could increase that continent’s per capita growth rate by as much as 2.6% 
a year (Gallup and Sachs, 2001). 
The results of the literature on the effect of poor health on economic growth are not clear-
cut, some authors finding a negative and significant effect, while others did not. The fact that 
traditional health measures (prevalence, incidence, mortality rate, life expectancy at birth) do 
not give a good indication of the disease burden, may explain that. By including diseases that 
cause early death but little disability such as diseases that do not cause death but do cause 
disability, the DALY gives a good indication of the disease burden (WHO, 2008) whatever 
the main causes of this burden.8 
3. Empirical framework 
The analysis of the effect of health on economic growth is based on the augmented 
neoclassical growth equation, which includes the global health status variable as a regressor 
combined with initial GDP per capita as catch up variable and other exogenous variables.  
 =  + 	
ℎ + ′ +  
Where yi is the annual growth rate of GDP per capita with subscript i designating the 
country; Healthi is the global health indicator;  is the matrix of the k control variables and εi 
is the independently and identically distributed error terms; α, β and δ are parameters to be 
estimated. Regional dummy variables are included to control for regional specific effects. 
3.1. Data and variables 
DALYs are available on the 2000-2004 period for 153 WHO member states (see countries’ 
list in Table A6). yi is thus the annual average growth rate on the 2000-2004 period; control 
                                                 
8
 70% of the disease burden is from communicable diseases in Africa, 70% is from non-communicable diseases 
in high income countries while the part of communicable and non-communicable diseases is equal in middle-
income countries (WHO, 2008). 
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variables are average values over the same period. DALYs per capita at the country level are 
not available on the whole period. DALYs are available for each WHO country (country 
DALY) in 2002 and 2004; and from 2000 to 2002 and 2004 at a regional level according to the 
WHO’s classification (regional DALY). In order to have comparable periods, we have several 
opportunities.  
First we can use country DALYs in 2002 or in 2004 (DALY 2002; DALY 2004) assuming 
that the figures are representative of the health status over the period under study (Columns 1 
and 2 in Table 1). Second, we can also use the average country DALY value, calculated with 
the 2002 and 2004 data (DALY 2002-2004, Column 3 in Table 1). Third, we calculate a 
corrected DALY. Under the hypothesis that the gap between the DALY of a country and the 
DALY of the WHO region is constant on the 2000-2004’s period, the regional DALY is 
weighted by the ratio of the 2004 country level DALY over the 2004 regional DALY 
(Column 4 in Table 1). It allows generating DALY at the country level over the whole period 
and then generates the average value for DALYs. More precisely: 
		
		 = 	
			 ×
 !"#$%&	'()*	#	+,,-
./0!#12	'()*	#	+,,-
		with 
 = 2000, 2001, 2002, 2004	
The causes of the disease burden differ according to income levels (see footnote 8). This 
characteristic is taken into account while calculating DALYs with respect to communicable 
diseases and to non-communicable diseases as well. Finally as malaria and HIV/AIDS 
constitute respectively a large part of the disease burden in low income countries, and are the 
fifth main diseases in the world (WHO, 2008), DALYs with respect to both diseases are also 
considered in the econometric analysis.  
We consider several control variables X, which are either assumed from the theoretical 
model or inferred from other cross-country analyses of Solow augmented growth regressions. 
Initial GDP per capita allows considering conditional convergence when it exhibits a negative 
effect on growth; annual growth rates of population and investment ratio to GDP have resp. a 
negative and positive effect on growth (e.g. Mankiw et al. 1992). In addition to the global 
health indicator, other human capital variables are included. Lagged female school enrollment 
rates are preferred to male school enrollment as it may also reflect the inequality level that has 
an impact on growth. Lagged variables may cope with endogeneity bias. 
CERDI, Etudes et Documents, E 2012.12 
 12
Our second group of control variables includes the Government consumption ratio to GDP, 
openness and inflation rates. The government consumption does not have a clear-cut effect on 
growth (Barro, 1992). Openness and inflation allows taking economic policy variables with 
resp. a positive and a negative effect on growth. A variable taken from Kaufmann and al. 
(2009) allows including institutional quality which positively affects growth.  
Summary statistics are reported in Table A1 and A2, Appendix A.  
3.2. Econometric specification 
OLS estimation of equation (1) is potentially biased. First there can be a simultaneity bias 
between global health status and growth (e.g. Bonnel 2000; Bloom, Canning and Malaney 
2000; Sachs et al. 1999, 2003; Strauss and Thomas, 2008; Schultz, 2008). Under the 
hypothesis that faster growing economies have a better health outcome, OLS estimates of 
health effects on growth are positively biased. Measurement errors of the global health 
indicator may also induce downward biased estimators (attenuation bias). To deal with these 
problems, we draw on instrumental variables techniques and therefore several instruments.  
The first is malaria ecology developed by Kiszewski et al. (2004) and first used in cross-
country regressions by Sachs (2003) and Carstensen and Gundlach (2006). Malaria ecology is 
built upon climatic factors and specific biological properties of each regionally dominant 
malaria vector which only reflects the forces of biological evolution and is thus independent 
from present health interventions and economic conditions. Moreover germs likely to be 
affected by economic conditions or public health interventions (like mosquito abundance, for 
example) do not enter the calculation of the index (Kiszewski et al. 2004; Carstensen and 
Gundlach 2006).  
The other instrument used in this paper is the proportion of each country’s population 
threatened by a risk of malaria transmission in 1994 (Sachs 2003). This indicator affects 
current economic growth only through health status and is unlikely affected by current 
economic conditions.  
4. Econometric results 
Equation (1) is estimated with the heteroskedastic-efficient two-step generalized method of 
moments (IV-GMM) estimator which generates efficient coefficients as well as consistent 
standard errors estimates. The efficiency gains of this estimator relative to the traditional 
CERDI, Etudes et Documents, E 2012.12 
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IV/2SLS estimator derive from the use of the optimal weighting matrix, the over-identifying 
restrictions of the model, and the relaxation of the independently and identically distributed 
(i.i.d.) assumption. For an exactly-identified model, the efficient GMM and traditional 
IV/2SLS estimators coincide, and under the assumptions of conditional homoskedasticity and 
independence, the efficient GMM estimator is the traditional IV/2SLS estimator (Hayashi 
2000 pp.206-13 and 226-27; Baum et al. 2007). 
4.1. Results 
Our results stress that health status is an important predictor of economic development on a 
large sample of poor and rich countries. Efficient-GMM estimations are presented in Table 1 
below. The quality of the instruments is either validated by the Shea R², or the statistic of 
Fisher and the Hansen over-identification test of the first stage estimation results presented in 
Table A4 (Appendix A). 
The effect of DALYs due to HIV/AIDS on economic development is not estimated for two 
reasons. First, we did not find a valid and relevant instrument for HIV/AIDS. The instrument 
used in the literature is the lagged HIV/AIDS variable (McDonald and Roberts, 2006) and we 
do not have relevant data for that. The second reason is that HIV/AIDS is always associated to 
co-infections that enter into the group of communicable and non-communicable diseases such 
as tuberculosis, hepatitis C, liver disease (see for example Sharifi-Mood and Metanat, 2006; 
Amin et al. 2004). We may thus suppose that the effect of HIV/AIDS may be caught by 
communicable and non-communicable DALYs. 
The first four columns report estimates with a global health indicator. Contrary to OLS 
estimates,9 Health is found to have a negative and statistically significant effect on economic 
growth thus validating the attenuation bias. This result is robust to variants of DALYs 
(columns 1 to 4). The marginal effect of DALY on growth is significant whatever its 
calculation (Table 1). Contrary to what expected, the coefficient and then the effect of 
DALYs for communicable diseases (Column 5) are not different to that of global DALYs. It 
may reflect the importance of communicable diseases in health status in the world and as a 
barrier to economic development. Malaria has however a strong negative effect on economic 
growth:  the coefficient of DALYs for malaria is higher (-0.365) than the coefficients of 
                                                 
9
 OLS estimates of equation (1) are reported in Table A3, Appendix A. 
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global DALYs or communicable DALY, also indicating that malaria is one among other 
health main causes. 
These results are in conformity with some important previous works. Moreover, the other 
explanatory variables present the expected signs apart from the population growth rate and the 
education variable. The convergence hypothesis is not rejected, inflation rate reduces 
economic growth and investment rate improves it. We also found that Government spending 
is negatively related to economic growth (Landau, 1983). As found in the literature (Knowles 
and Owen 1994, Berthélemy et al. 1997), education is not significant.  
CERDI, Etudes et Documents, E 2012.12 
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Table 1. Two-step GMM estimation of economic effects of DALYs per capita 
 Dependent variable: GDP per capita growth 
Independent variables (1) (2) (3) (4) (5) (6) (7) 
        
DALY in 2002 -0.111**       
 (2.47)       
DALY in 2004  -0.108**      
  (2.55)      
DALY 2002-2004   -0.110**     
   (2.53)     
Corrected DALYs    -0.108***    
    (2.61)    
Communicable DALY     -0.119***   
     (2.64)   
Infectious DALY      -0.157**  
      (2.54)  
Malaria DALY       -0.365** 
       (2.36) 
Log initial GDP per capita -0.010*** -0.008** -0.009** -0.009*** -0.009** -0.008** -0.005* 
 (2.61) (2.49) (2.57) (2.59) (2.56) (2.44) (1.74) 
Investment ratio to GDP 0.127*** 0.105*** 0.116*** 0.102** 0.110*** 0.123*** 0.129*** 
 (3.71) (2.58) (3.13) (2.54) (2.86) (3.27) (3.38) 
Population growth rate 0.002 0.002 0.002 0.002 0.003 0.002 0.004* 
 (0.55) (0.87) (0.71) (0.82) (1.31) (0.60) (1.77) 
Government consumption -0.108*** -0.119*** -0.114*** -0.117*** -0.117*** -0.111*** -0.134*** 
 (2.94) (3.26) (3.12) (3.21) (3.14) (3.02) (3.76) 
Openness 0.006 0.004 0.005 0.004 0.003 0.005 0.002 
 (1.60) (1.34) (1.52) (1.27) (1.03) (1.33) (0.62) 
Inflation rate -0.018** -0.018** -0.018** -0.016** -0.014* -0.009 -0.026** 
 (2.13) (2.29) (2.22) (2.04) (1.91) (1.09) (2.10) 
School enrolment lagged -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 
 (0.97) (1.21) (1.09) (1.18) (1.06) (0.35) (1.25) 
Institutions -0.001 -0.003 -0.002 -0.002 -0.001 -0.000 -0.003 
 (0.19) (0.73) (0.45) (0.61) (0.16) (0.09) (0.64) 
Constant 0.147*** 0.136*** 0.141*** 0.141*** 0.127*** 0.111*** 0.080*** 
 (2.93) (2.92) (2.95) (2.99) (3.00) (2.91) (2.65) 
Observations 138 138 138 138 138 138 138 
R² 0.345 0.396 0.380 0.393 0.410 0.374 0.411 
Shea R2 0.146 0.232 0.190 0.208 0.191 0.157 0.483 
Fisher F statistic  6.811 13.726 9.750 11.984 10.924 8.869 54.800 
(p-value) 0.0016 0.0000 0.0001 0.0000 0.0000 0.0003 0.0000 
Hansen OID p-value 0.467 0.481 0.470 0.624 0.764 0.708 0.274 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics in parentheses.  
 
 
4.2. Robustness analyses 
Our previous results may still be questioned. First, they may be due to the large health 
outcome gap between developed and developing countries, and may not satisfactorily explain 
development levels gaps between developing or developed countries. Secondly, it is relevant 
to investigate the role of health in the explanation of development differential within countries 
which share a common characteristic related to poor basic health infrastructures. Our growth 
regression is therefore estimated on a low and middle-income countries sub-sample of which 
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results are presented in Table 2 and the first stage estimation results are presented in Table A5 
Appendix A. They are similar to those obtained for the whole sample, namely, health remains 
an important determinant of economic growth. Coefficients are smaller than those previously 
obtained on the whole sample (0.083 against 0.108 for Corrected DALYs; 0.324 against 0.365 
for Malaria DALYs). 
These results suppose that there are other limiting global factors to growth other than 
health such as education quality which is not satisfactorily measured. We cannot show 
evidence of a complementarity between health and education which is probably the result of a 
poor measurement of education. 
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Table 2: Two-steps GMM estimation of economic effect of DALYs per capita, developing countries 
 
 Dependent variable: GDP per capita growth 
Independent. variables (1) (2) (3) (4) (5) (6) (7) 
        
DALY in 2002 -0.077**       
 (2.01)       
DALY in 2004  -0.084**      
  (2.07)      
DALY 2002-2004   -0.080**     
   (2.05)     
Corrected DALYs    -0.083**    
    (2.10)    
Communicable DALY     -0.091**   
     (2.05)   
Infectious DALY      -0.108**  
      (2.06)  
Malaria DALY       -0.324* 
       (1.88) 
Log initial GDP per capita -0.008** -0.008* -0.008* -0.008** -0.008* -0.007* -0.005 
 (1.98) (1.91) (1.95) (1.97) (1.95) (1.86) (1.44) 
Investment ratio to GDP 0.128*** 0.110** 0.119*** 0.109** 0.117*** 0.127*** 0.124*** 
 (3.25) (2.45) (2.86) (2.46) (2.78) (3.02) (2.62) 
Population growth rate -0.002 -0.002 -0.002 -0.002 -0.001 -0.001 -0.002 
 (0.71) (0.92) (0.81) (0.86) (0.19) (0.56) (0.96) 
Government consumption -0.098*** -0.109*** -0.103*** -0.107*** -0.109*** -0.102*** -0.130*** 
 (2.66) (2.90) (2.80) (2.86) (2.85) (2.76) (3.21) 
Openness 0.001 -0.001 0.000 -0.001 -0.001 -0.000 -0.001 
 (0.15) (0.10) (0.04) (0.15) (0.18) (0.06) (0.21) 
Inflation rate -0.021** -0.021** -0.021** -0.019** -0.018** -0.015* -0.028* 
 (2.14) (2.17) (2.16) (2.04) (1.98) (1.67) (1.94) 
School enrolment lagged -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 
 (0.70) (0.93) (0.81) (0.88) (0.72) (0.15) (1.01) 
Institutions 0.002 0.001 0.002 0.001 0.002 0.003 0.002 
 (0.52) (0.18) (0.36) (0.21) (0.45) (0.60) (0.35) 
Constant 0.130*** 0.134*** 0.132*** 0.137*** 0.124*** 0.104*** 0.102*** 
 (3.11) (3.05) (3.09) (3.08) (3.13) (3.24) (2.90) 
Observations 103 103 103 103 103 103 103 
R² 0.447 0.446 0.452 0.447 0.464 0.468 0.421 
SheacR2 0.189 0.265 0.229 0.241 0.211 0.199 0.486 
Fisher F statistic 7.748 13.360 10.178 11.784 10.090 9.725 48.174 
(p-value) 0.0008 0.0000 0.0001 0.0000 0.0001 0.0002 0.0000 
Hansen OID p-value 0.689 0.671 0.679 0.796 0.876 0.862 0.381 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics in parentheses.  
 
 
4.3. Effect of a standard deviation decrease of the DALYs on growth 
In the previous subsection, we showed that population health measured by the global 
burden of disease has a negative impact on economic development. This result can be 
quantified by simulating the effect of a one standard deviation increase of the DALYs on 
economic growth. The first and third columns of Table 3 present respectively the change in 
economic growth due to one standard deviation decrease of the different measures of DALYs 
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for the whole sample and that of developing countries. For the total DALYs and 
communicable diseases DALYs, the effect ranges from 0.44 to 0.50 percentage points on the 
whole sample and around 0.30 percentage points on the developing countries sample. More 
importantly, this health impact doubles for infectious diseases and is multiplied by ten for 
malaria DALYs. The second column of Table 3 shows the average economic growth level for 
the whole samples after experiencing one standard deviation decrease of the DALYs. The 
average economic growth changes from 4% to around 5.5%, and is even around 10% for 
malaria DALYs. A similar figure is observed for developing countries sample in the last 
column. This is largely due to high standard deviation of malaria indicator (around 0.154 
against 0.062).         
Table 3: Effect of a standard deviation decrease of the global burden of disease on economic growth 
    Whole sample Developing countries sample 
  Change (∆y) Effect (y+∆y) Change (∆y) Effect (y+∆y) 
DALY in 2002   0.00504 0,04537 0.00297 0,04547 
DALY in 2004 0.00455 0,04488 0.00337 0,04587 
DALY 2002-2004   0.00473 0,04507 0.00315 0,04565 
Corrected DALYs 0.00442 0,04476 0.00324 0,04574 
Communicable DALY   0.00534 0,04568 0.00405 0,04655 
Infectious DALY   0.00976 0,05010 0.00566 0,04816 
Malaria DALY   0.05630 0,09663 0.05609 0,09859 
 
5. Concluding remarks 
This article contributes to the debate on the relationship between health outcomes and 
economic performance by paying a particular attention to global health status measurement 
issues. We argue that, traditional health indicators such as life expectancy and mortality rates 
are inadequate to explain the overall health status in a population since they present many 
drawbacks and are devoted to a particular health problem. An accurate health indicator must 
measure the gap between current health status and an ideal health situation where the entire 
population lives to an advanced age, free of disease and disability. This is what the disability-
adjusted life year (DALY) proposed by the World Bank and WHO since 1993 tries to 
measure.  
Several remarks can be drawn from our results. First, as the results were very similar 
whatever the estimation of DALYs used (corrected DALYs, country DALYs or regional 
DALYs), it appears that regional DALYs represent correctly the disease burden of each 
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country inside the considered region. Estimating country DALYs each year does not seem to 
be necessary. Secondly we highlight and confirm the role of poor health in the economic 
development. This result has been showed by using a global health outcome which takes into 
consideration mortality, morbidity, and disability consequences of health as well. Thus, we 
estimated the effect of global health, and not only of a specific disease or disease fatal 
consequence.   However, this indicator that can be calculated for a group of particular diseases 
such as communicable diseases, or for a specific disease, such as malaria, allowed us to 
estimate the economic burden of diseases that remain an important impediment to economic 
development especially in low income countries.  
These results call for important and relevant policy recommendations, especially for the 
developing world. Given the low health status in poor countries, health issues represent a 
challenge rather than a handicap since it offers them more rooms and possibilities to boost 
their economic growth and reduce their poverty levels.  
For this challenge to be transformed into an opportunity, accurate health policies should be 
implemented, such as efficient health spending. More attention should be paid to water and 
sanitation that are the main determinants of communicable diseases such as diarrheal diseases. 
International community should also help national health policy makers through their support 
and pressure. This could be done through increasing health sector assistance and the 
promotion of good institutions. Brain drain in health sector also should be transformed into 
brain gain through support to physicians from poor countries.  
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6. Appendix A: Tables 
 
Table A1: Variables characteristics and sources 
  mean min max 
Coef of 
Var. Std error Source 
GDP. growth 0,04 -0,06 0,13 0,65 0,03 WDI 
Corrected DALYs 0,27 0,10 0,83 0,65 0,17 WHO 
DALY 2002-2004 0,27 0,10 0,89 0,66 0,18 WHO 
DALY in 2002 0,28 0,10 0,95 0,68 0,19 WHO 
DALY in 2004 0,26 0,10 0,82 0,64 0,17 WHO 
Communicable DALY 0,13 0,004 0,64 1,30 0,17 WHO 
Infectious DALY 0,08 0,001 0,56 1,47 0,12 WHO 
Malaria DALY 0,01 0,00 0,09 1,95 0,02 WHO 
Malaria Ecology 3,86 0,00 31,55 1,77 6,85 Sachs 2003 
Malaria Risk 0,37 0,00 1,00 1,18 0,44 Sachs 2003 
Investment ratio to GDP 0,21 0,08 0,57 0,33 0,07 WDI 
Population growth rate 1,38 -1,10 7,07 0,86 1,20 WDI 
Government 
consumption 0,16 0,05 0,53 0,40 0,07 WDI 
Openness 0,86 0,22 2,68 0,48 0,42 WDI 
Inflation rate 0,10 -0,01 2,03 2,36 0,23 WDI 
School enrollment  100,77 36,53 144,52 0,17 16,75 WDI 
rule of law -0,05 -1,90 2,01 -19,93 0,96 
Kaufmann 
Kraay 
 
 
 
 
Table A2: Correlation between the main variables 
  
GDP 
Growth 
Corrected 
DALYs 
DALY 
2002-2004 
DALY in 
2002 
DALY in 
2004 
Communicable 
DALY 
Infectious 
DALY 
Corrected DALYs 0,005 1,00 
DALY 2002-2004 0,03 0,99* 1,00 
DALY in 2002 0,03 0,97* 0,99* 1,00 
DALY in 2004 0,03 1,00* 0,99* 0,97* 1,00 
Commun. DALY -0,02 0,99* 0,98* 0,97* 0,98* 1,00 
Infectious DALY -0,08 0,95* 0,96* 0,95* 0,94* 0,97* 1,00 
Malaria DALY 0,03 0,84* 0,83* 0,80* 0,84* 0,84* 0,78* 
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Table A3: OLS estimation of the economic effects of health status 
 Dependent variable: GDP per capita growth 
Independent. variables (1) (2) (3) (4) (5) (6) (7) 
        
DALY in 2002 -0.013       
 (0.49)       
DALY in 2004  -0.019      
  (0.60)      
DALY 02-04   -0.016     
   (0.54)     
Corrected DALYs    -0.023    
    (0.81)    
Communicable DALY     -0.034   
     (1.20)   
Infectious DALY      -0.044  
      (1.43)  
Malaria DALY       -0.183 
       (1.62) 
Log initial GDP per capita -0.004 -0.004 -0.004 -0.005* -0.005** -0.005* -0.005* 
 (1.55) (1.57) (1.56) (1.72) (1.99) (1.98) (1.85) 
Investment ratio to GDP 0.119*** 0.116*** 0.118*** 0.115*** 0.114*** 0.117*** 0.116*** 
 (3.71) (3.64) (3.69) (3.61) (3.59) (3.62) (3.54) 
Population growth rate 0.005* 0.005** 0.005** 0.005** 0.006** 0.005* 0.006** 
 (1.96) (2.02) (1.99) (2.01) (2.16) (1.93) (2.36) 
Government consumption -0.088*** -0.089*** -0.089*** -0.089*** -0.091*** -0.091*** -0.100*** 
 (2.84) (2.81) (2.82) (2.81) (2.80) (2.86) (2.97) 
Openness 0.004 0.004 0.004 0.004 0.004 0.004 0.003 
 (1.26) (1.19) (1.23) (1.17) (1.07) (1.14) (0.93) 
Inflation rate -0.025** -0.025** -0.025** -0.024** -0.023** -0.021** -0.026** 
 (2.46) (2.40) (2.43) (2.36) (2.36) (2.34) (2.31) 
School enrolment lag -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 -0.000 
 (0.28) (0.34) (0.31) (0.40) (0.45) (0.28) (0.62) 
Institutions -0.004 -0.004 -0.004 -0.004 -0.004 -0.004 -0.004 
 (1.19) (1.21) (1.19) (1.18) (1.02) (1.05) (0.98) 
Constant 0.051* 0.055* 0.053* 0.060** 0.064*** 0.058*** 0.060*** 
 (1.76) (1.82) (1.77) (2.10) (2.65) (2.83) (2.62) 
Regional dummies yes yes yes yes yes yes yes 
Observations 153 153 153 153 153 153 153 
R² 0.378 0.380 0.379 0.382 0.389 0.391 0.388 
Note: ***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics in parentheses. 
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Table A4: first stage estimation results (whole sample) ++ 
 (1) (2) (3) (4) (5) (6) (7) 
 DALY 
2002 
DALY 
2004 
DALY 
02-04 
Corr. 
DALY 
Comm. 
DALY 
Infect. 
DALY 
Mal. 
DALY 
        
Malaria Ecology 0.006** 0.006** 0.006** 0.005* 0.004 0.003* 0.002*** 
 (2.16) (2.43) (2.36) (1.97) (1.64) (1.77) (5.54) 
Malaria Risk 0.084* 0.087** 0.085** 0.102** 0.104*** 0.075** 0.015*** 
 (1.82) (2.44) (2.13) (2.56) (2.76) (2.33) (2.96) 
Regional dummies yes yes yes yes yes yes yes 
Observations 138 138 138 138 138 138 138 
Fisher F-Stat. 6.81 13.72 9.75 11.98 10.92 8.86 54.80 
Shea partial R² 0.14 0.23 0.19 0.20 0.19 0.15 0.48 
Hansen OID p-val. 0.46 0.48 0.47 0.62 0.76 0.70 0.27 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parentheses. 
++ We show only the coefficients of the instruments, but all the exogenous variables are included in the regressions 
 
 
 
 
 
 
Table A5: first stage estimation results (Developing countries) ++ 
 (3) (4) (2) (1) (5) (6) (7) 
 DALY 
2002 
DALY 
2004 
DALY 02-
04 
Corr. 
DALY 
Comm. 
DALY 
Infect. 
DALY 
Mal. 
DALY 
        
Malaria Ecology 0.006** 0.006** 0.006** 0.005** 0.004* 0.004* 0.002*** 
 (2.40) (2.61) (2.58) (2.11) (1.75) (1.95) (5.36) 
Malaria Risk 0.123** 0.110*** 0.117*** 0.128*** 0.125*** 0.104*** 0.015** 
 (2.44) (2.97) (2.72) (3.14) (3.08) (2.90) (2.50) 
Regional dummies yes yes yes yes yes yes yes 
Observations 103 103 103 103 103 103 103 
Fisher F-Stat. 7.74 13.36 10.17 11.78 10.09 9.72 48.17 
Shea partial R² 0.19 0.26 0.23 0.24 0.21 0.20 0.48 
Hansen OID p-
val. 
0.69 0.67 0.68 0.79 0.87 0.86 0.38 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parentheses. 
++ We show only the coefficients of the instruments, but all the exogenous variables are included in the regressions 
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Table A6: List of countries 
Low-income  Lower-middle-income  Upper-middle-income  High-income 
Benin  Albania  Argentina  Bahrain 
Burkina Faso  Algeria  Belarus  Estonia 
Burundi  Armenia  Belize  Israel 
Cambodia  Azerbaijan  Botswana  Kuwait 
Central African Republic  Bhutan  Brazil  Malta 
Chad  Bolivia  Bulgaria  Oman 
Comoros  Cameroon  Chile  Slovenia 
Congo, Dem. Rep.  Cape Verde  Costa Rica  Trinidad and Tobago 
Cote d'Ivoire  China  Croatia  United Arab Emirates 
Eritrea  Colombia  Dominica  Australia 
Ethiopia  Congo, Rep.  Fiji  Austria 
Gambia, The  Djibouti  Gabon  Belgium 
Ghana  Dominican Republic  Grenada  Canada 
Guinea  Ecuador  Jamaica  Czech Republic 
Guinea-Bissau  Egypt, Arab Rep.  Kazakhstan  Denmark 
Kenya  El Salvador  Latvia  Finland 
Kyrgyz Republic  Georgia  Libya  France 
Liberia  Guatemala  Lithuania  Germany 
Madagascar  Guyana  Malaysia  Greece 
Malawi  Honduras  Mauritius  Hungary 
Mali  India  Mexico  Iceland 
Mauritania  Indonesia  Panama  Ireland 
Mozambique  Iran, Islamic Rep.  Poland  Italy 
Nepal  Jordan  Romania  Japan 
Niger  Lesotho  Russian Federation  Korea, Rep. 
Nigeria  Macedonia, FYR  Seychelles  Luxembourg 
Pakistan  Maldives  South Africa  Netherlands 
Rwanda  Moldova  St. Kitts and Nevis  New Zealand 
Sao Tome and Principe  Mongolia  St. Lucia  Norway 
Senegal  Morocco  St. Vincent and the Grenadines  Portugal 
Sierra Leone  Namibia  Suriname  Slovak Republic 
Tajikistan  Nicaragua  Turkey  Spain 
Tanzania  Paraguay  Uruguay  Sweden 
Togo  Peru  Venezuela, RB  Switzerland 
Uganda  Philippines     United Kingdom 
Uzbekistan  Sri Lanka     United States 
Vietnam  Sudan       
Yemen, Rep.  Swaziland       
Zambia  Syrian Arab Republic       
Zimbabwe  Thailand       
   Tonga       
   Tunisia       
    Ukraine         
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Table A7: Literature review on the effect of health on economic growth 
Study Health indicator 
Coefficient 
(standard error) data Estimator Other covariates 
Barro and Lee 
(1994) 
Life 
expectancy 0.073 (0.013) 
Two periods 
n=85 for 
1965–75, 
n=95 for 
1975–85 
SUR with country random 
effects 
Male and female secondary 
schooling, I/GDP, G/GDP, 
log(1+black market premium), 
revolutions 
Cuddington 
and Hancock 
(1994) 
AIDS 
0.2- 0.3% 
points lost in 
the medium 
case and 1.2- 
1.5 in the 
lower case 
Each five year 
age cohort 
from 1985-
2010 in 
Malawi 
simulation Na 
Barro and 
Sala IMartin 
(1995)  
Life 
expectancy 0.058 (0.013) 
Two periods 
n=87 for 
1965–75, 
n=97 for 
1975–85 
SUR with country random 
effects 
Male and female secondary and 
higher education, log(GDP) ·  human 
capital, public spending on 
education/ GDP, investment/GDP, 
government consumption/GDP, 
log(1+black market premium), 
political instability, growth rate in 
terms of trade 
Barro (1996) Life 
expectancy 0.042 (0.014) 
Three periods 
1965–75, 
n=80; 1975–
85, n=87; 
1985–90, 
N=84 
3SLS using lagged values 
of some regressions as 
instruments, period random 
effects 
Male secondary and higher 
schooling, log(GDP) ·  male 
schooling, log fertility rate, 
government consumption ratio, rule 
of law index, terms of trade change, 
democracy index, demo- cracy 
index squared, inflation rate, 
continental dummies 
Caselli, 
Esquivel, and 
Lefort (1996) 
Life 
expectancy -0.001 (0.032) 
25-year panel 
at 5-year 
intervals, 
1960–85, 
n=91 
GMM (Arellano- Bond 
method) 
Male and female schooling, I/GDP, 
G/GDP, black market premium, 
revolutions 
Sachs and 
Warner 
(1997) 
Life 
expectancy 45.48 (2.60) 25-year cross-
section, N=79 OLS 
Openness, openness xlog(GDP), 
land-locked, government saving, 
tropical climate, institutional 
quality, natural resource exports, 
growth in economically active 
population minus population growth life 
expectancy 
squared 
-5.40  (2.41) 
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Study Health indicator 
Coefficient 
(standard error) data Estimator Other covariates 
Bloom and 
Sachs (1998) 
Life 
expectancy 0.037 (0.011) 
25-year cross-
section, 1965–
90, n=65 
OLS 
Log secondary schooling, openness, 
institutional quality, central 
government deficit, percentage area 
in tropics, log coastal population 
density, log inland population 
density, total population growth 
rate, working- age population 
growth rate, Africa dummy 
Bloom and 
Malaney 
(1998)  
Life 
expectancy 0.027 (0.107) 
25-year cross-
section, 1965–
90, n=77 
OLS 
Population growth, growth of 
economically active populations, 
log years of secondary schooling, 
natural resource abundance, 
openness, institutional quality, 
access to ports, average government 
savings, tropics, ratio of coastline 
distance to land area 
Bloom and 
Williamson 
(1998)  
Life 
expectancy 0.040 (0.010) 
25-year cross-
section, 1965–
90, n=78 
OLS 
Population growth rate, working- 
age population growth rate, log 
years of secondary schooling, 
natural resource abundance, 
openness, institutional quality, 
access to port, average government 
savings rate, tropics dummy, ratio of 
coastline to land area 
Gallup, 
Sachs. and 
Mellinger 
(1999) 
life 
expectancy 2.4  (1.34) 
25-year cross-
section, 1965–
90, n=75 
2SLS with malaria index 
instrument by temperate 
(temperate, boreal, and 
polar eco-zones), desert 
(tropical and subtropical 
deserts), subtropical (non 
desert subtropical), and 
tropical (non desert 
tropical) 
Years of secondary schooling, 
openness, quality of public 
institutions, population within 100 
kilometers of the coast, malaria 
index in 1966, change in malaria 
index from 1966 to 1994 Malaria index 
1966 -2.6  (0.67) 
Hamoudi and  
Sachs (1999) 
Life 
expectancy 0.072 (0.020) 15-year cross-
section, 1980–
95, n=78 
OLS 
Institutional quality, openness, net 
government savings, tropics land 
area, log coastal population density, 
population growth rate, working-age 
population growth rate, Africa 
dummy 
Infant 
mortality rate 
-0.0002  
(0.00008) 
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Study Health indicator 
Coefficient 
(standard error) data Estimator Other covariates 
Bloom, 
Canning and 
Malaney 
(2000) 
Life 
expectancy 0.019 (0.012) 
25-year cross 
section, 1965–
90, n=80 
2SLS 
Log of ratio of total population to 
working-age population, tropics, log 
of years of secondary schooling, 
openness, institutional quality, 
population growth rate, working age 
population growth rate 
Bonnel 
(2000) HIV/AIDS 
-0.7% points 
per year 
1990- 1997 
African 
countries 
OLS and 2SLS 
Log GDP 1990, Log phone per 
capita, Macro rating, Law rating, 
Primary enrollment rate, Malaria 
morbidity and dummy 
Ranis and 
Steward 
(2000)  
Life 
expectancy 0.06 (0.016) 
N=73 
developing 
countries 
Cross country 
1960-1992 
2SLS using lagged values 
as instruments 
change in the log of life expectancy 
1962-82, gross domestic investment, 
income distribution, regional 
dummies, 
Bhargava, 
Jamison, Lau, 
and Murray 
(2001) 
Adult survival 
rate 0.358 (0.114) 
25-year panel 
at 5-year 
intervals, 
1965–90, n= 
92 
Dynamic random effects Tropics, openness, log fertility, log (Investment/GDP) 
 ASR xlog 
(GDPC) -0.048 (0.016) 
Mayer (2001) 
Probability of 
survival by 
age and 
gender groups 
0,8 and 1,5% 
Panel of 18 
countries over 
1975, 1980 
and 1985 
Granger-type causality 
tests 
Schooling, investment, Government 
consumption and fertility 
Gallup and 
Sachs (2001) 
falciparum 
malaria index -2.5   (0.71) 25-year cross-
section, 1965–
90, n=75 
2SLS with the prevalence 
of 53 different Anopheles 
mosquito vectors in each 
country in 1952 as 
instrument 
Years of secondary schooling, 
openness, quality of public 
institutions, population within 100 
kilometers of the coast, malaria 
index in 1966, change in malaria 
index from 1966 to 1994 life 
expectancy 3.0  (0.84) 
Arora (2001) 
Stature at 
Adulthood, 
Life 
Expectancy 
30- 40% 
10 developed 
countries over 
the course of 
100 to 125 
years 
Cointegration and Error-
Correction Na 
Sachs (2003) Malaria Risk -1.43 (0.35) 
Cross- country 
regression in 
1995, N=101 
2SLS with Malaria 
Ecology as instrument rules of law 
Bloom,  
Canning and 
Sevilla (2004) 
Life 
expectancy 0.040  (0.019) 
every 10 years 
from 1960 to 
1990 
Nonlinear two stage least 
squares with lagged as 
instrument 
Capital, labor, Schooling, 
Experience, Technological catch-up 
coefficient, Percentage of land area 
in the tropics and Governance 
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Study Health indicator 
Coefficient 
(standard error) data Estimator Other covariates 
Aguayo-Rico, 
and Guerra-
Turrubiates 
(2005)  
Health 
services,   
0,0021    
(0.006) 
N=104 panel 
1970, 1980 
and 1990 
OLS capital, labor, schooling, Environment Lifestyles 
0.0016 
(0.0002) 
total health 
index 
0.0015 
(0.0001) 
 Bloom and 
Canning 
(2005) 
Adult survival 
rate 0.03 (0.009) 
5 years panel 
from 1960 to 
1995 
OLS 
capital, labor, schooling, 
Environment, Technological catch-
up coefficient, Percentage of land 
area in the tropics, Openness, 
Percentage oft land within 100 
kilometers of the coast, Ethno-
linguistic fractionalization, 
Institutional quality 
Lorentzen,  
McMillan and 
Wacziarg 
(2005)° 
adult 
mortality rate -8.564  (2.23) 
cross-country 
1960-2000  
2SLS with malaria 
ecology, climatic factors 
and geographic 
characteristic as 
instruments 
investment, education, Government 
consumption, openness, population, 
interstate battle death crude death 
rate 
-145.765  
(64.78) 
infant 
mortality rate -31.644  (6.92) 
Acemoglu 
and Johnson 
(2006)  
Life 
expectancy -1.43 (2.24) 
Panel 1940-
1980, N=234 
and 47 
countries 
2SLS with predicted 
mortality, as instrument Population, investment, education 
Carstensen 
and Gundlach 
(2006) 
Malaria risk -1.31 (0.42) 
Cross country 
of 45 
countries 
2SLS with malaria ecology 
as instrument 
Institutional quality, climatic factors 
and geographic characteristic 
McDonald 
and Roberts 
(2006)  
HIV/AIDS -0.59% 
Panel of each 
five year from 
1960 to 1998 
for all 
countries. 
2SLS with lagged as 
instruments and GMM 
Income per capita, investment, 
population growth, schooling, 
proteins, malaria, infant mortality, 
life expectancy. 
Weil (2007)  
height, adult 
survival rates, 
and age at 
menarche 
9.9-12.3% 
income 
variation 
explained by 
health  
cross- country 
regression in 
1996, N=73 
2SLS with health inputs as 
instruments investment, education 
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7. Appendix B: Figures 
Figure 1B: Relationship between Corrected DALY, traditional health indicators and GDP per capita.   
 
Source: Authors’ construction with data from World Bank and WHO. 
 
 
 
Figure 2B: Relationship between Communicable Corrected DALY, traditional health indicators and GDP per 
capita. 
 
Source: Authors’ construction with data from World Bank and WHO. 
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Figure 3B: Relationship between Non Communicable Corrected DALY, traditional health indicators and GDP 
per capita. 
 
Source: Author’s construction with data from World Bank and WHO. 
 
 
 
Figure 4B: Relationship between Malaria Corrected DALY, traditional health indicators and GDP per capita. 
 
Source: Authors’ construction with data from World Bank and WHO. 
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